Alice S Chen-Plotkin
Overview
Explore the profile of Alice S Chen-Plotkin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
4147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Carceles-Cordon M, Weintraub D, Chen-Plotkin A
Neuron
. 2023 Apr;
111(10):1531-1546.
PMID: 37028431
Cognitive impairment occurs in most individuals with Parkinson's disease (PD), exacting a high toll on patients, their caregivers, and the healthcare system. In this review, we begin by summarizing the...
12.
Neel D, Basu H, Gunner G, Bergstresser M, Giadone R, Chung H, et al.
Neuron
. 2023 Mar;
111(8):1222-1240.e9.
PMID: 36917977
Mitochondrial dysfunction and axon loss are hallmarks of neurologic diseases. Gasdermin (GSDM) proteins are executioner pore-forming molecules that mediate cell death, yet their roles in the central nervous system (CNS)...
13.
Tropea T, Albuja I, Cousins K, Irwin D, Lee E, Chen-Plotkin A
Ann Neurol
. 2023 Mar;
93(5):1045-1046.
PMID: 36892304
No abstract available.
14.
Tropea T, Waligorska T, Xie S, Nasrallah I, Cousins K, Trojanowski J, et al.
Ann Clin Transl Neurol
. 2022 Dec;
10(1):18-31.
PMID: 36518085
Objective: To determine if plasma tau phosphorylated at threonine 181 (p-tau181) distinguishes pathology-confirmed Alzheimer's disease (AD) from normal cognition (NC) adults, to test if p-tau181 predicts cognitive and functional decline,...
15.
Zuroff L, Wisse L, Glenn T, Xie S, Nasrallah I, Habes M, et al.
J Alzheimers Dis Rep
. 2022 Sep;
6(1):411-430.
PMID: 36072364
Background: Episodic memory decline is a hallmark of Alzheimer's disease (AD). Subjective memory complaints (SMCs) may represent one of the earliest signs of impending cognitive decline. The degree to which...
16.
Diaz-Ortiz M, Seo Y, Posavi M, Carceles Cordon M, Clark E, Jain N, et al.
Science
. 2022 Aug;
377(6608):eabk0637.
PMID: 35981040
Many risk loci for Parkinson's disease (PD) have been identified by genome-wide association studies (GWASs), but target genes and mechanisms remain largely unknown. We linked the GWAS-derived chromosome 7 locus...
17.
Weintraub D, Posavi M, Fontanillas P, Tropea T, Mamikonyan E, Suh E, et al.
Ann Clin Transl Neurol
. 2022 Jun;
9(7):936-949.
PMID: 35762106
Objective: To develop a clinico-genetic predictor of impulse control disorder (ICD) risk in Parkinson's disease (PD). Methods: In 5770 individuals from three PD cohorts (the 23andMe, Inc.; the University of...
18.
Walker I, Cousins K, Siderowf A, Duda J, Morley J, Dahodwala N, et al.
Parkinsonism Relat Disord
. 2022 Jun;
100:33-36.
PMID: 35700626
Motor features of Parkinson's disease (PD) are heterogeneous and well-studied; non-tremor features of postural instability and gait dysfunction (PIGD) have been linked to worse outcomes and Alzheimer's disease (AD) co-pathology....
19.
Shen J, Amari N, Zack R, Skrinak R, Unger T, Posavi M, et al.
Ann Neurol
. 2022 May;
92(2):255-269.
PMID: 35593028
Objective: Using a multi-cohort, discovery-replication-validation design, we sought new plasma biomarkers that predict which individuals with Parkinson's disease (PD) will experience cognitive decline. Methods: In 108 discovery cohort PD individuals...
20.